CROs/Service Providers

BTE launches Research Services

Thursday, September 10, 2015

BTE, a global innovator in objective human performance evaluation and rehabilitation technology, has launched its new Research Services group. For over 35 years, BTE has pioneered evidence-based systems to support quantitative muscle testing (QMT) for employers, physicians and other healthcare providers. In recent months, BTE has expanded into supporting the needs of drug development professionals and research scientists with our knowhow and measurement technologies. The Research Services group leverages the technical expertise and scientific leadership already present in BTE’s Rehabilitation Equipment and Workforce Solutions business units.

[Read More]

Quotient expands data sciences capabilities

Wednesday, September 9, 2015

Quotient Clinical, a translational pharmaceutics company, has expanded its data sciences services in response to increasing customer demand, doubling the footprint of its facilities in Edinburgh and Nottingham, as well as increasing its specialist headcount and appointing a new vice president.

[Read More]

Icon applies IBM Watson Clinical Trial Matching

Wednesday, September 9, 2015

Icon, a global CRO, is working with IBM to help reduce the time and costs of drug development, while also offering patients enhanced quality-of-care by connecting them to relevant clinical trials. Icon will tap Watson’s cognitive computing power to help automate the cumbersome process of identifying patients who meet the criteria for a clinical trial, and to analyze protocols to assess trial feasibility and identify optimal trial sites.

[Read More]

Britain’s NHS approves Mytrus e-informed consent

Wednesday, September 9, 2015

Mytrus, a technology and services company working in clinical trials, has announced its software platform for electronic informed consent has received approval for use by Britain’s National Health Service (NHS). It is the first time e-Consent technology will be used in a trial in England.

[Read More]

BioClinica announces eHealth App xChange

Wednesday, September 9, 2015

BioClinica, a specialty clinical trials technology and services provider, has created the eHealth App xChange, an alliance channel for disruptive technology innovation across life sciences and healthcare. BioClinica’s eHealth App xChange provides healthcare payers, providers, researchers, regulators and patients with access to transformative applications integrated with and delivered through BioClinica’s eHealth Cloud.

[Read More]

MNX opens logistics facility in Amsterdam

Thursday, August 27, 2015

Irvine, Calif.-based MNX Global Logistics has opened a dedicated supply chain and logistics facility in Amsterdam, the Netherlands, just outside of Amsterdam Airport Schiphol. The facility, which has validated temperature-controlled supply chain capabilities, will serve as the operations and warehousing hub for the company’s life sciences and medical device customers throughout Europe.

[Read More]

Hepalink to acquire Cytovance

Wednesday, August 26, 2015

Hepalink USA, a China-based global supplier of heparin sodium API, has entered into a definitive agreement to acquire Cytovance Biologics, a biopharmaceutical contract development manufacturing (CDMO) company, for $205.68 million in cash plus certain contingent payments.

[Read More]